RecruitingNCT04076449

Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy

Studying Epilepsy syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
yuanli Zhao
Principal Investigator
Li Ma, MD, PhD
Beijing Tiantan Hospital
Enrollment
200 enrolled
Eligibility
18-70 years · All sexes
Timeline
20192026

Study locations (2)

Collaborators

Peking University International Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04076449 on ClinicalTrials.gov

Other trials for Epilepsy syndrome

Additional recruiting or active studies for the same condition.

See all trials for Epilepsy syndrome

← Back to all trials